SynAct Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-	-89.98	-224.5	-105.71	-76.7
Depreciation & Amortization	-	0.61	75.34	-	-
Stock-Based Compensation	-	10.07	7.88	-	-
Other Adjustments	-	10.98	87.92	0.71	0.09
Change in Receivables	13.3	-19.63	19.87	-19.31	-1.21
Changes in Accounts Payable	-7.04	7.33	5.11	0.18	1.44
Changes in Accrued Expenses	1.22	-5.97	5.39	-1.22	6.87
Changes in Income Taxes Payable	-	8.43	8.47	7.86	4.63
Changes in Other Operating Activities	-	-0.2	-0.09	-0.07	-0.11
Operating Cash Flow	7.49	-89.2	-100.18	-117.56	-65
Purchases of Investments	-	-	0.37	0.03	-0.01
Investing Cash Flow	-	-	0.37	0.03	-0.01
Issuance of Common Stock	92.21	94.14	59.46	228.95	80
Net Common Stock Issued (Repurchased)	92.21	94.14	59.46	228.95	80
Other Financing Activities	-1.75	-6.74	-5.48	-28.23	-5.68
Financing Cash Flow	90.46	87.41	53.98	200.71	74.32
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-	0.61	-0.03	1.06	0.13
Net Cash Flow	97.95	-1.79	-45.82	83.18	9.32
Free Cash Flow	7.49	-89.2	-100.18	-117.56	-65
Free Cash Flow Per Share	0.15	-1.75	-3.08	-4.26	-2.51
Levered Free Cash Flow	-8.51	-72.2	-121.59	-92.45	-56.48
Unlevered Free Cash Flow	-6.06	-71.43	-121.8	-91.19	-56.38